{
    "id": 25532,
    "fullName": "PDGFRB R561C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PDGFRB R561C lies within the cytoplasmic domain of the Pdgfrb protein (UniProt.org). R561C results in constitutive phosphorylation of Pdgfrb, activation of downstream signaling, and is transforming in cell culture (PMID: 26455322).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5159,
        "geneSymbol": "PDGFRB",
        "terms": [
            "PDGFRB",
            "CD140B",
            "IBGC4",
            "IMF1",
            "JTK12",
            "KOGS",
            "PDGFR",
            "PDGFR-1",
            "PDGFR1",
            "PENTT"
        ]
    },
    "variant": "R561C",
    "createDate": "10/18/2016",
    "updateDate": "10/18/2016",
    "referenceTranscriptCoordinates": {
        "id": 175080,
        "transcript": "NM_002609",
        "gDna": "chr5:g.150125571G>A",
        "cDna": "c.1681C>T",
        "protein": "p.R561C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8949,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tasigna (nilotinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB R561C in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 26545,
                "profileName": "PDGFRB R561C"
            },
            "therapy": {
                "id": 829,
                "therapyName": "Nilotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8950,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB R561C in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 26545,
                "profileName": "PDGFRB R561C"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8948,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB R561C in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 26545,
                "profileName": "PDGFRB R561C"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26545,
            "profileName": "PDGFRB R561C",
            "profileTreatmentApproaches": [
                {
                    "id": 10668,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "PDGFRB R561C"
                },
                {
                    "id": 10669,
                    "name": "PDGFR-beta Inhibitor",
                    "profileName": "PDGFRB R561C"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 175081,
            "transcript": "XM_011537658",
            "gDna": "chr5:g.150125571G>A",
            "cDna": "c.1681C>T",
            "protein": "p.R561C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175080,
            "transcript": "NM_002609",
            "gDna": "chr5:g.150125571G>A",
            "cDna": "c.1681C>T",
            "protein": "p.R561C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175079,
            "transcript": "XM_011537659",
            "gDna": "chr5:g.150125571G>A",
            "cDna": "c.1681C>T",
            "protein": "p.R561C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}